FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366827459> ?p ?o ?g. }

• W4366827459 endingPage "1326" @default.
• W4366827459 startingPage "1326" @default.
• W4366827459 abstract "In cancer combination therapy, a multimodal delivery vector is used to improve the bioavailability of multiple anti-cancer hydrophobic drugs. Further, targeted delivery of therapeutics along with simultaneous monitoring of the drug release at the tumor site without normal organ toxicity is an emerging and effective strategy for cancer treatment. However, the lack of a smart nano-delivery system limits the application of this therapeutic strategy. To overcome this issue, a PEGylated dual drug, conjugated amphiphilic polymer (CPT-S-S-PEG-CUR), has been successfully synthesized by conjugating two hydrophobic fluorescent anti-cancer drugs, curcumin (CUR) and camptothecin (CPT), through an ester and a redox-sensitive disulfide (-S-S-) linkage, respectively, with a PEG chain via in situ two-step reactions. CPT-S-S-PEG-CUR is spontaneously self-assembled in the presence of tannic acid (TA, a physical crosslinker) into anionic, comparatively smaller-sized (~100 nm), stable nano-assemblies in water in comparison to only polymer due to stronger H-bond formation between polymer and TA. Further, due to the spectral overlap between CPT and CUR and a stable, smaller nano-assembly formation by the pro-drug polymer in water in presence of TA, a successful Fluorescence Resonance Energy Transfer (FRET) signal was generated between the conjugated CPT (FRET donor) and conjugated CUR (FRET acceptor). Interestingly, these stable nano-assemblies showed a preferential breakdown and release of CPT in a tumor-relevant redox environment (in the presence of 50 mM glutathione), leading to the disappearance of the FRET signal. These nano-assemblies exhibited a successful cellular uptake by the cancer cells and an enhanced antiproliferative effect in comparison to the individual drugs in cancer cells (AsPC1 and SW480). Such promising in vitro results with a novel redox-responsive, dual-drug conjugated, FRET pair-based nanosized multimodal delivery vector can be highly useful as an advanced theranostic system towards effective cancer treatment." @default.
• W4366827459 created "2023-04-25" @default.
• W4366827459 creator A5009502942 @default.
• W4366827459 creator A5013641421 @default.
• W4366827459 creator A5019756474 @default.
• W4366827459 creator A5034011054 @default.
• W4366827459 creator A5037562966 @default.
• W4366827459 creator A5041474939 @default.
• W4366827459 date "2023-04-24" @default.
• W4366827459 modified "2023-09-29" @default.
• W4366827459 title "Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy" @default.
• W4366827459 cites W1801904186 @default.
• W4366827459 cites W1973203731 @default.
• W4366827459 cites W1976194786 @default.
• W4366827459 cites W1981576205 @default.
• W4366827459 cites W1998990083 @default.
• W4366827459 cites W2004620214 @default.
• W4366827459 cites W2005482676 @default.
• W4366827459 cites W2017916544 @default.
• W4366827459 cites W2019908060 @default.
• W4366827459 cites W2023096851 @default.
• W4366827459 cites W2024382973 @default.
• W4366827459 cites W2033694065 @default.
• W4366827459 cites W2034365540 @default.
• W4366827459 cites W2035050097 @default.
• W4366827459 cites W2052971123 @default.
• W4366827459 cites W2072175441 @default.
• W4366827459 cites W2073676974 @default.
• W4366827459 cites W2077605558 @default.
• W4366827459 cites W2099758152 @default.
• W4366827459 cites W2104916446 @default.
• W4366827459 cites W2130166533 @default.
• W4366827459 cites W2178066395 @default.
• W4366827459 cites W2261551157 @default.
• W4366827459 cites W2278428896 @default.
• W4366827459 cites W2291461503 @default.
• W4366827459 cites W2399140686 @default.
• W4366827459 cites W2521457636 @default.
• W4366827459 cites W2522346927 @default.
• W4366827459 cites W2554496701 @default.
• W4366827459 cites W2607452090 @default.
• W4366827459 cites W2755932918 @default.
• W4366827459 cites W2759628737 @default.
• W4366827459 cites W2767074976 @default.
• W4366827459 cites W2790084239 @default.
• W4366827459 cites W2805204183 @default.
• W4366827459 cites W2810971566 @default.
• W4366827459 cites W2845838257 @default.
• W4366827459 cites W2890672962 @default.
• W4366827459 cites W2892565790 @default.
• W4366827459 cites W2899536024 @default.
• W4366827459 cites W2900155913 @default.
• W4366827459 cites W2902321607 @default.
• W4366827459 cites W2937509930 @default.
• W4366827459 cites W2941086073 @default.
• W4366827459 cites W2942338404 @default.
• W4366827459 cites W2951888558 @default.
• W4366827459 cites W2952097821 @default.
• W4366827459 cites W2960698964 @default.
• W4366827459 cites W2965390913 @default.
• W4366827459 cites W2976684613 @default.
• W4366827459 cites W2981252772 @default.
• W4366827459 cites W2998427746 @default.
• W4366827459 cites W3001063306 @default.
• W4366827459 cites W3004877228 @default.
• W4366827459 cites W3005772695 @default.
• W4366827459 cites W3015804616 @default.
• W4366827459 cites W3044418844 @default.
• W4366827459 cites W3048280156 @default.
• W4366827459 cites W3113136405 @default.
• W4366827459 cites W3128777129 @default.
• W4366827459 cites W3136588234 @default.
• W4366827459 cites W3192447201 @default.
• W4366827459 cites W3198866967 @default.
• W4366827459 cites W3199272207 @default.
• W4366827459 cites W3201882315 @default.
• W4366827459 cites W4206669581 @default.
• W4366827459 cites W4213031115 @default.
• W4366827459 cites W4313886773 @default.
• W4366827459 doi "https://doi.org/10.3390/pharmaceutics15051326" @default.
• W4366827459 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37242568" @default.
• W4366827459 hasPublicationYear "2023" @default.
• W4366827459 type Work @default.
• W4366827459 citedByCount "0" @default.
• W4366827459 crossrefType "journal-article" @default.
• W4366827459 hasAuthorship W4366827459A5009502942 @default.
• W4366827459 hasAuthorship W4366827459A5013641421 @default.
• W4366827459 hasAuthorship W4366827459A5019756474 @default.
• W4366827459 hasAuthorship W4366827459A5034011054 @default.
• W4366827459 hasAuthorship W4366827459A5037562966 @default.
• W4366827459 hasAuthorship W4366827459A5041474939 @default.
• W4366827459 hasBestOaLocation W43668274591 @default.
• W4366827459 hasConcept C10138342 @default.
• W4366827459 hasConcept C112613896 @default.
• W4366827459 hasConcept C121332964 @default.
• W4366827459 hasConcept C12554922 @default.
• W4366827459 hasConcept C15083742 @default.
• W4366827459 hasConcept C155672457 @default.

• next